| ACTN3 genotype influences muscle performance through the regulation of calcineurin signaling JT Seto, KGR Quinlan, M Lek, XF Zheng, F Garton, DG MacArthur, ... The Journal of clinical investigation 123 (10), 4255-4263, 2013 | 161 | 2013 |
| Mitochondria mediate cell membrane repair and contribute to Duchenne muscular dystrophy MC Vila, S Rayavarapu, MW Hogarth, JH Van der Meulen, A Horn, ... Cell Death & Differentiation 24 (2), 330-342, 2017 | 133 | 2017 |
| Mitochondrial redox signaling enables repair of injured skeletal muscle cells A Horn, JH Van der Meulen, A Defour, M Hogarth, SC Sreetama, A Reed, ... Science signaling 10 (495), eaaj1978, 2017 | 127 | 2017 |
| Fibroadipogenic progenitors are responsible for muscle loss in limb girdle muscular dystrophy 2B MW Hogarth, A Defour, C Lazarski, E Gallardo, J Diaz Manera, ... Nature communications 10 (1), 2430, 2019 | 117 | 2019 |
| TGF-β–driven muscle degeneration and failed regeneration underlie disease onset in a DMD mouse model DAG Mázala, JS Novak, MW Hogarth, M Nearing, P Adusumalli, CB Tully, ... JCI insight 5 (6), 2020 | 104 | 2020 |
| Dysregulation of mitochondrial Ca2+ uptake and sarcolemma repair underlie muscle weakness and wasting in patients and mice lacking MICU1 V Debattisti, A Horn, R Singh, EL Seifert, MW Hogarth, DA Mazala, ... Cell reports 29 (5), 1274-1286. e6, 2019 | 84 | 2019 |
| Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy MW Hogarth, PJ Houweling, KC Thomas, H Gordish-Dressman, L Bello, ... Nature communications 8 (1), 14143, 2017 | 68 | 2017 |
| α-Actinin-3 deficiency is associated with reduced bone mass in human and mouse N Yang, A Schindeler, MM McDonald, JT Seto, PJ Houweling, M Lek, ... Bone 49 (4), 790-798, 2011 | 60 | 2011 |
| Annexin A2 links poor myofiber repair with inflammation and adipogenic replacement of the injured muscle A Defour, S Medikayala, JH Van der Meulen, MW Hogarth, N Holdreith, ... Human molecular genetics 26 (11), 1979-1991, 2017 | 54 | 2017 |
| Analysis of the ACTN3 heterozygous genotype suggests that α-actinin-3 controls sarcomeric composition and muscle function in a dose-dependent fashion MW Hogarth, FC Garton, PJ Houweling, T Tukiainen, M Lek, ... Human molecular genetics 25 (5), 866-877, 2016 | 53 | 2016 |
| Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle JS Novak, MW Hogarth, JF Boehler, M Nearing, MC Vila, R Heredia, ... Nature communications 8 (1), 941, 2017 | 43 | 2017 |
| Effect of endurance exercise on microRNAs in myositis skeletal muscle—A randomized controlled study JF Boehler, MW Hogarth, MD Barberio, JS Novak, S Ghimbovschi, ... PLoS One 12 (8), e0183292, 2017 | 38 | 2017 |
| The effect of ACTN3 gene doping on skeletal muscle performance FC Garton, PJ Houweling, D Vukcevic, LR Meehan, FXZ Lee, M Lek, ... The American Journal of Human Genetics 102 (5), 845-857, 2018 | 31 | 2018 |
| Elusive sources of variability of dystrophin rescue by exon skipping MC Vila, MB Klimek, JS Novak, S Rayavarapu, K Uaesoontrachoon, ... Skeletal muscle 5, 1-12, 2015 | 31 | 2015 |
| Morpholino‐induced exon skipping stimulates cell‐mediated and humoral responses to dystrophin in mdx mice MC Vila, JS Novak, M Benny Klimek, N Li, M Morales, AG Fritz, K Edwards, ... The Journal of pathology 248 (3), 339-351, 2019 | 20 | 2019 |
| Cooperative International Neuromuscular Research Group (CINRG); Pegoraro, E.; Hoffman, EP; Head, SI; North, KN Evidence for ACTN3 as a genetic modifier of Duchenne muscular … MW Hogarth, PJ Houweling, KC Thomas, H Gordish-Dressman, L Bello Nat. Commun 8, 14143, 2017 | 19 | 2017 |
| Single-cell and spatial transcriptomics identify a macrophage population associated with skeletal muscle fibrosis G Coulis, D Jaime, C Guerrero-Juarez, JM Kastenschmidt, PK Farahat, ... Science advances 9 (27), eadd9984, 2023 | 15 | 2023 |
| Pathogenic role and therapeutic potential of fibro-adipogenic progenitors in muscle disease MW Hogarth, P Uapinyoying, DAG Mázala, JK Jaiswal Trends in molecular medicine 28 (1), 8-11, 2022 | 11 | 2022 |
| Anoctamin 5 knockout mouse model recapitulates LGMD2L muscle pathology and offers insight into in vivo functional deficits G Thiruvengadam, SC Sreetama, K Charton, M Hogarth, JS Novak, ... Journal of Neuromuscular Diseases 8 (s2), S243-S255, 2021 | 8 | 2021 |
| Humoral and cell mediated immune response to new dystrophin after morpholino-induced exon skipping therapy in dystrophin-deficient mdx mice K Nagaraju, M Vila, J Novak, J Boehler, M Hogarth, A Zhang, T Kinder, ... NEUROMUSCULAR DISORDERS 28, S90-S90, 2018 | 1 | 2018 |
Jyoti JaiswalProfessor, The George Washington University; Children's National HospitalDirección de correo verificada de cnmc.org
